CELZ Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Creative Medical Technology Holdings Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerCELZ

Market Cap8.3M

Cash RunwayRunway > 12 months

Next Catalyst2027-01-31

Public Research Snapshot

Creative Medical Technology Holdings Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for Infusion using Cell Therapy.

Pipeline

Asset	Indication	Modality	Stage	Public Note
Infusion	n/a	Cell Therapy	n/a	Public pipeline row
CELZ-201 Administration	Type 1 Diabetes \| Diabetes Mellitus, Type 1	n/a	Phase 1 \| Phase 2	Public pipeline row
Prior Burn Pit Exposure	n/a	n/a	n/a	Public pipeline row
CELZ-201-DDT	Chronic Back Pain \| Degenerative Disc Disease Lumbar	n/a	n/a	Public pipeline row

Catalyst Preview

Catalyst	Timing	Asset	Confidence
Clinical Trial Completion	2027-01-31	CELZ-201 Administration	Low
Clinical Trial Completion	2029-05-01	Prior Burn Pit Exposure	Low
Clinical Trial Completion	2029-05-01	n/a	Low

Cash Runway Preview

Estimated cash runway: Runway > 12 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT06053242	Phase 1 \| Phase 2	RECRUITING	45	2026-05-01
NCT05626712	Phase 1 \| Phase 2	RECRUITING	18	2027-01-31
NCT07562243	n/a	NOT_YET_RECRUITING	1000	2029-05-01
NCT07137559	n/a	AVAILABLE	n/a	n/a

Scientific Context

catalyst_date_estimated | 2029-05-01
catalyst_date_estimated | 2029-05-01
catalyst_type | Clinical Trial Completion
catalyst_type | Clinical Trial Completion
literature_publication | Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs.

Want the full CELZ research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.